Skip to main content
Frontiers in Cellular and Infection Microbiology logoLink to Frontiers in Cellular and Infection Microbiology
. 2014 Jan 31;4:7. doi: 10.3389/fcimb.2014.00007

Virulence profiling of Shiga toxin-producing Escherichia coli recovered from domestic farm animals in Northwestern Mexico

Bianca A Amézquita-López 1, Beatriz Quiñones 2,*, Bertram G Lee 2, Cristóbal Chaidez 1,*
PMCID: PMC3908320  PMID: 24551599

Abstract

Shiga toxin-producing Escherichia coli (STEC) is a zoonotic enteric pathogen that causes human gastrointestinal illnesses. The present study characterized the virulence profiles of O157 and non-O157 STEC strains, recovered from domestic animals in small rural farms within the agricultural Culiacan Valley in Mexico. Virulence genes coding for adhesins, cytotoxins, proteases, subtypes of Shiga toxin (Stx), and other effectors were identified in the STEC strains by PCR. The genotyping analysis revealed the presence of the effectors nleA, nleB, nleE, and nleH1-2, espK, and espN in the O157:H7 and O111:H8 STEC strains. Furthermore, the genes encoding the autoagglutinating adhesin (Saa) and subtilase (SubA) were exclusively identified in the O8:H19 eae-negative strains. The adhesin (iha) and the silent hemolysin (sheA) genes were detected in 79% of the O157 and non-O157 strains. To examine the relative toxicities of the STEC strains, a fluorescent Vero cell line, Vero-d2EGFPs, was employed to measure the inhibition of protein synthesis by Stx. Analysis of culture supernatants from serotype O8:H19 strains with the stx gene profile stx1a, stx2a, and stx2c and serotypes O75:H8 and O146:H8 strains with the stx gene profile stx1a, stx1c, and stx2b, resulted in a significant reduction in the Vero-d2EGFP fluorescent signal. These observations suggest that these non-O157 strains may have an enhanced ability to inhibit protein synthesis in Vero cells. Interestingly, analysis of the stx2c-positive O157:H7 strains resulted in a high fluorescent signal, indicating a reduced toxicity in the Vero-d2EGFP cells. These findings indicate that the O157 and non-O157 STEC strains, recovered in the Culiacan Valley, display distinct virulence profiles and relative toxicities in mammalian cells and have provided information for evaluating risks associated with zoonotic STEC in this agricultural region in Mexico.

Keywords: Escherichia coli, STEC, virulence genes, Shiga toxin, Vero cells, Mexico, zoonosis, foodborne pathogen

Introduction

Shiga toxin-producing Escherichia coli (STEC) is considered to be a major cause of foodborne disease and can cause a wide variety of disease symptoms in humans, ranging from watery and bloody diarrhea to the life-threatening diseases such as hemorrhagic colitis, and hemolytic uremic syndrome (HUS) (Tarr et al., 2005; Gyles, 2007; Karmali et al., 2010; Scallan et al., 2011; Melton-Celsa et al., 2012). Cattle are considered to be the major carrier of STEC strains (Gyles, 2007; Ferens and Hovde, 2011). However, additional studies that examined important animal reservoirs for these bacterial pathogens have indicated that small domestic ruminants, including sheep and goats, have been implicated as carriers of STEC (Ogden et al., 2005; Gyles, 2007; La Ragione et al., 2009; Ferens and Hovde, 2011; Mandrell, 2011). Furthermore, STEC strains have been also detected in other domestic and wild animals, including cats, dogs, rodents, deer, birds, feral pigs, chickens, and insects (Cooley et al., 2007; Ferens and Hovde, 2011; Mandrell, 2011).

Severe disease in humans has been associated with more than 100 serotypes of STEC (Gould et al., 2009; Mathusa et al., 2010). Serotype O157:H7 is responsible for most outbreaks in the United States (Karmali, 2009; Hoefer et al., 2011; Melton-Celsa et al., 2012). Additional epidemiological studies have indicated that six non-O157 serogroups, O26, O45, O103, O111, O121, and O145, have been associated with severe disease symptoms in North America (Johnson et al., 2006; Gould et al., 2009; Stigi et al., 2012). Additionally, STEC of serogroups, O91, O104, O113, and O128 have been reported to be significant causes of human infections worldwide (Brooks et al., 2005; Bettelheim, 2007; Mathusa et al., 2010; Beutin and Martin, 2012). Thus, these findings have indicated that strains with certain non-O157 serogroups may be potentially as virulent as strains with the O157:H7 serotype (Bettelheim, 2007; Coombes et al., 2011; Beutin and Martin, 2012; Stigi et al., 2012).

The production of Shiga toxins (Stx) by STEC contributes to the development of the life-threatening disease symptoms in humans (Karmali et al., 1983; Karmali, 1989). The Stx family has been categorized into two major types, Stx1 and Stx2. In particular, distinct subtypes of Stx1, Stx1a, Stx1c and Stx1d, have been identified (Scheutz and Strockbine, 2005; Scheutz et al., 2012). By contrast, the Stx2 group consists of a heterogeneous and diverse group of subtypes, and seven subtypes of Stx2, corresponding to Stx2a, Stx2b, Stx2c, Stx2d, Stx2e, Stx2f, and Stx2g, have been documented (Scheutz and Strockbine, 2005; Scheutz et al., 2012). Epidemiological and molecular genotyping studies of STEC have demonstrated that there is a strong correlation between strains with certain stx2 subtypes and severe illness such as bloody diarrhea and HUS. STEC strains positive for the subtypes stx2a, stx2c, or stx2d were found to be associated with an enhanced virulence and with the development of the HUS in humans (Friedrich et al., 2002; Beutin et al., 2004; Bielaszewska et al., 2006; Persson et al., 2007). Other subtypes of Stx1 and Stx2 appear to be associated with mild disease or asymptomatic carriage (Friedrich et al., 2002, 2003; Beutin et al., 2004; Bielaszewska et al., 2006; Scheutz et al., 2012).

Many STEC strains that produce Stx do not cause HUS, demonstrating that additional virulence factors may be required to cause illness in humans (Bolton, 2011). For example, virulence factors present on pathogenicity islands, such as the locus of enterocyte effacement (LEE) and the non-LEE effectors, have been implicated in host colonization and disease (Bettelheim, 2007; Bolton, 2011; Coombes et al., 2011). In particular, a key virulence factor responsible for the attachment to intestinal epithelial cells is the LEE-encoded eae gene (Jerse et al., 1990; Kaper, 1998). An additional adhesin, Iha, the iron-regulated gene A homolog adhesin, may contribute to the attachment of LEE-positive and LEE-negative strains (Tarr et al., 2000; Schmidt et al., 2001). Moreover, the Nle effectors, not encoded by the LEE region, are proposed to be involved in altering the host cell response and have been linked to the disease severity associated with non-O157 STEC (Coombes et al., 2008; Karmali et al., 2010; Melton-Celsa et al., 2012). Other chromosomal and plasmid virulence genes, encoding proteases (espP), cytotoxins (subA), and adhesins (saa), may contribute to STEC pathogenesis by allowing bacterial attachment and colonization of the human epithelium (Karmali et al., 2010; Bolton, 2011; Melton-Celsa et al., 2012). The detection of these virulence genes in STEC strains would provide key information for the identification of risk factors that may potentially contribute to the development of human disease.

In the present study, a molecular characterization study was conducted to further examine the virulence potential of STEC strains, previously recovered from feces of domestic animals in small rural farms within the agricultural Culiacan Valley in Northwestern Mexico (Amézquita-López et al., 2012). The small rural farms were located in communities where the primary purpose of raising livestock is for local consumption (Amézquita-López et al., 2012). To determine the virulence profiles of STEC strains from animal reservoirs in this agricultural region in Mexico, the present study identified the stx subtypes as well as several virulence factors that have been associated with pathogenic STEC strains. The activity of the Stx subtypes, expressed by the tested STEC strains, was also further examined to obtain more detailed information on their ability to inhibit protein synthesis in mammalian cells.

Materials and methods

Bacterial strains and growth conditions

A subset of 29 STEC strains, previously recovered from various animal reservoirs in the Culiacan Valley in Mexico (Amézquita-López et al., 2012), was studied (Table 1). The subset of strains was selected based on serotype and on the recovery from distinct dates, sampling sites and animal reservoirs (Amézquita-López et al., 2012).

Table 1.

List of E. coli O157 and non-O157 strains analyzed in this study.

Strain Serotypea Sampling date Source Regionb
RM8744 O157:H7 18-Nov-08 Cattle Iraguato
RM8745 O73:H4 02-Dec-08 Sheep El Castillo
RM8747 O15:NT 22-Jul-08 Cattle Agua Caliente
RM8748 O73:NT 22-Jul-08 Cattle Agua Caliente
RM8749 O20:H4 12-Aug-08 Sheep El Castillo
RM8752 O75:H8 07-Oct-08 Sheep Cofradia de Navolato
RM8753 O157:H7 02-Dec-08 Sheep Cofradia de Navolato
RM8755 O111:H8 20-Jan-09 Sheep Cofradia de Navolato
RM8756 O146:H21 20-Jan-09 Sheep Jotagua
RM8759 O157:H7 20-Jan-09 Sheep Cofradia de Navolato
RM8760 O75:H8 20-Jan-09 Sheep Cofradia de Navolato
RM8761 O146:H21 20-Jan-09 Sheep El Castillo
RM8762 O146:H8 20-Jan-09 Sheep El Castillo
RM8763 O75:H8 03-Feb-09 Sheep Cofradia de Navolato
RM8768 O157:H7 20-Jan-09 Cattle Cofradia de Navolato
RM8772 O8:H19 17-Feb-09 Cattle El Castillo
RM8776 O8:H19 03-Feb-09 Cattle Iraguato
RM8778 O75:H8 25-Feb-09 Sheep Cofradia de Navolato
RM8781 O157:H7 25-Feb-09 Sheep Cofradia de Navolato
RM8922 O157:H7 10-Mar-09 Cattle Cofradia de Navolato
RM8923 O75:H8 10-Mar-09 Cattle Cofradia de Navolato
RM8928 O157:H4 10-Mar-09 Cattle El Castillo
RM8929 O75:H8 10-Mar-09 Sheep Cofradia de Navolato
RM9450 O157:H7 10-Mar-09 Sheep Cofradia de Navolato
RM9452 O157:H7 26-May-09 Sheep Cofradia de Navolato
RM9454 O157:H7 26-May-09 Cattle Cofradia de Navolato
RM9456 O157:H7 07-Apr-09 Cattle Cofradia de Navolato
RM9458 O157:H7 24-Mar-09 Chicken Agua Caliente
RM9462 O157:H7 03-Jun-09 Cattle Iraguato
RM13865 O75:H8 07-Apr-09 Cattle Cofradia de Navolato
a

NT, Non-typeable H-antigen.

b

Sampling sites correspond to regions in the Culiacan Valley, Sinaloa, Mexico (Amézquita-López et al., 2012).

The method employed to isolate the STEC strains (Table 1) from fecal samples from various domestic animals was previously described (Amézquita-López et al., 2012). The characteristics and sources of the STEC reference strains that were used in this study are described in Table 2. Bacteria were routinely propagated under aerobic conditions at 37°C on Luria-Bertani (LB) agar (Difco, Detroit, MI).

Table 2.

Shiga toxin-producing Escherichia coli reference strains used in this study.

Strain Other strain designations Serotype Source Location Provider or referencea
RM2084 EDL-933; DEC 4f O157:H7 Meat United States ECRC (Reid et al., 1999)
RM7004 E32511; TW02883 O157:H Human United States The STEC Center (Schmitt et al., 1991)
RM7005 EH250; TW081611 O118:H12 Human Belgium The STEC Center (Piérard et al., 1998)
RM7006 B2F1; TW01393 O91:H21 Human Canada The STEC Center (Ito et al., 1990)
RM7110 NADC2228; S1191 O139:NM Pig United States Evelyn Dean-Nystrom (Weinstein et al., 1988)
RM7203 SC-0012 O168:H8 Coyote United States Michael B. Cooley (Cooley et al., 2013)
RM7369 SP-0082-G9 ONT:H7 Pig United States Michael B. Cooley (Cooley et al., 2013)
RM7508 MA146B-A7 O128:H2 Deer United States Michael B. Cooley (Cooley et al., 2013)
RM7519 F260-H2 O113:H21 Cattle United States Michael B. Cooley (Cooley et al., 2013)
a

Contact information of strain providers: ECRC, E. coli Reference Center, College of Agricultural Sciences, The Pennsylvania State University, University Park, PA, USA; The STEC Center, National Food Safety and Toxicology Center, Michigan State University, East Lansing, MI, USA; Michael B. Cooley, USDA/ARS, Western, Regional Research Center, Produce Safety and Microbiology Research Unit, Albany, CA, USA; Evelyn Dean-Nystrom, Iowa State University, National Animal Disease Center, Veterinary Microbiology and Preventive Medicine, Ames, Iowa, USA.

Polymerase chain reaction for amplification of stx subtypes and other virulence genes

For the detection of stx subtypes and other virulence genes, the following STEC reference strains (Table 2) were used as a control for the PCR amplification of ent/espL2, espK, espN, espP, etpD, ihA, katP, nleA, nleB, nleE, nleH1-2, sheA, stx1a, and stx2a (RM2084); stx2c (RM7004); stx2b (RM7005); saa and stx2d (RM7006); stx2f (RM7007); stx2e (RM7110); stx2g (RM7203); stx1d (RM7369); stx1c (RM7508); hlyA (RM10227). All PCR amplifications were performed by using primers as shown in Table 3. As template for the PCR reaction, cultures of the STEC strains were grown aerobically in tryptic soy broth (Beckton Dickinson, Sparks, MD) for 24 h with constant shaking (200 rpm) at 37°C, and 100 μL of the bacterial cultures were collected by centrifugation at 2000 ×g for 5 min. Cell pellets were resuspended in 100 μl of HyPure™ molecular biology-grade water (HyClone Laboratories, Inc., Logan, UT) and incubated at 95°C for 20 min, as in previous studies (Quiñones et al., 2011, 2012). The lysates were centrifuged at 2000 ×g for 5 min, and the supernatants were collected and frozen until further use. The PCR amplifications consisted of a 25 μl reaction mixture, each containing 5 μL of the bacterial crude lysate, 0.5 μM of each primer (Eurofins MWG Operon, Huntsville, AL), and 12.5 μl of 2× GoTaq® Green Master Mix (Promega Corporation, Madison, WI). The reaction mixtures were placed in a Dyad Peltier Thermal Cycler (Bio-Rad Laboratories, Hercules, CA), as in previous studies (Amézquita-López et al., 2012). The virulence genes were amplified with PCR cycling conditions, as described in the references listed in Table 3. Amplified products were analyzed in 2% agarose gels containing 0.04 μl/ml GelRed Nucleic Acid Stain (Phenix Research, Candler, NC).

Table 3.

List of DNA oligonucleotides used in this study for PCR amplification.

Target genea Forward sequence (5′ → 3′) Reverse sequence (5′ → 3′) Amplicon size (bp) Reference
ent/espL2 CACATCATTAGAAGTTCATT AGTCCTGCTCCCATAGCAAA 342 Quiñones et al., 2012
espK GTAGCGCCACAGACAGCATA ATCAGGCATCCCTTCAACAC 242 Kyle et al., 2012
espN TTTCTTTCGTGACGCTGATG GCACCGGAGAATCATCGTAT 155 Kyle et al., 2012
espP GCACTGTCTGGCGGTGAATA CGTCCAGATTCCCGTTTATG 202 Quiñones et al., 2012
etpD TTGGATGACGGCGAAACTG AGATGATACGCTGTTGGGAG 85 Bugarel et al., 2010b
hlyA GTCTGCAAAGCAATCCGCTGCAAATAAA CTGTGTCCACGAGTTGGTTGATTAG 561 Kerényi et al., 2005
iha GTGATGATTGTCTCGGCATC GTAACTGGCTGGCATTCCWC 207 Kyle et al., 2012
katP GCGGAAGAGAAGATGACTGG GCACCATGTGCTTTACCAAA 277 Quiñones et al., 2012
nleA TGGATTAACDGCTCARGTDGTTCG GCATTGGTAAGYARGGCATA 267 Kyle et al., 2012
nleB GGAAGTTTGTTTACAGAGACG AAAATGCCGCTTGATACC 297 Coombes et al., 2008
nleE GTATAACCAGAGGAGTAGC GATCTTACAACAAATGTCC 260 Coombes et al., 2008
nleH1-2 GCCTGATAATCGTGTTTTATC CGCATAATCCACTGGAGGTAA 295 Kyle et al., 2012
saa CCAATCAACAGTTTCGTCAA GCAATAGCCTGTTCATCACG 166 Quiñones et al., 2012
sheA GAGGCGAATGATTATGACTG ACTTCAGGTACCTCAAAGAG 920 Kerényi et al., 2005
stx1a CACGTTACAGCGTGTTGCA CGCCCACTGAGATCATCC 219 Kyle et al., 2012
stx1c GAACGAAATAATTTATATGT CTCATTAGGTACAATTCT 555 Koch et al., 2001
stx1d CTTTTCAGTTAATGCGATTGCT AACCCCATGATATCGACTGC 192 Bürk et al., 2003
stx2a AGATATCGACCCCTCTTGAA GTCAACCTTCACTGTAAATG 969 Nakao et al., 2002
stx2b TATACGATGACACCGGAAGAAG CCTGCGATTCAGAAAAGCAGC 300 Nakao et al., 2002
stx2c TTTTATATACAACGGGTA GGCCACTTTTACTGTGAATGTA 163 Nakao et al., 2002; Zheng et al., 2008
stx2d CTTTATATACAACGGGTG CTGAATTGTGACACAGATTAC 359 Zheng et al., 2008
stx2e CAGGAAGTTATATTTCCGTAGG GTATTCTCTTCCTGACACCTTC 911 Nakao et al., 2002
stx2f TTTACTGTGGATTTCTCTTCGC TCAGTAAGATCCTGAGGCTTG 875 Nakao et al., 2002
stx2g GTTATATTTCTGTGGATATC GAATAACCGCTACAGTA 573 Leung et al., 2003
subA CGGCTTATCATCCTGTCAGC TATAGCTGTTGCTTCTGACG 233 Quiñones et al., 2012
a

The stx1 and stx2 subtypes are listed with new stx nomenclature, as recently described (Feng et al., 2011; Scheutz et al., 2012)

Vero cell-based method to detect STX activity

The Stx activity of the STEC strains was measured using a Vero cell line, Vero-d2EGFP, that harbored a destabilized variant (t1/2 = 2 h) of the enhanced green fluorescent protein (EGFP) (Quiñones et al., 2009; Quiñones and Swimley, 2011). To monitor the Stx-induced inhibition of protein synthesis, the tested STEC strains (Table 1), the Stx-expressing O157:H7 strain RM2084 (positive control) (Table 2), and the Stx-negative O157:H4 strain RM8928 (Amézquita-López et al., 2012) (negative control) were inoculated in 1 ml of sterile LB broth (Difco, Detroit, MI). All E. coli strains were grown aerobically for 24 h at 37°C with shaking at 200 rpm and were then centrifuged at 2000 ×g for 15 min. The culture supernatants were filter-sterilized using 0.45 μm polyvinylidene fluoride syringe filters (Durapore® membranes, Millipore Corporation, Billerica, MA) and were frozen at −20°C until further use (Quiñones and Swimley, 2011). One day prior to intoxication, the Vero-d2EGFP cells were seeded at 10,000 cells per well in Greiner black 96-well microplates with clear bottoms (VWR International, Aurora, CO) and were grown at 5% CO2 and 37°C under humidified conditions in Ham's F-12 complete medium, supplemented with 10% fetal bovine serum and 1% penicillin-streptomycin (Gibco BRL, Grand Island, NY) (Quiñones et al., 2009; Quiñones and Swimley, 2011). The Vero-d2EGFP cells were then exposed to Ham's F-12 complete medium containing a tenfold dilution of the cell-free supernatants from each strain and were incubated for 16 h at 37°C in a 5% CO2 humidified incubator. The EGFP fluorescence from the Vero-d2EGFP cells was measured using a Synergy HT Multi-Detection Microplate Reader (BioTek, Winooski, VT) with the 485/20 nm excitation filter and the 528/20 nm emission filter (Quiñones et al., 2009; Quiñones and Swimley, 2011). All measurements were performed in triplicate, and the results were expressed as percentages of the fluorescence values obtained for culture supernatant-treated Vero-d2EGFP cells when compared to the fluorescence values from control Vero-d2EGFP cells incubated without culture supernatants. To determine statistical differences in the Stx activity among the STEC strains, the results were analyzed by performing a k-means clustering using the Hartigan and Wong algorithm (Hartigan and Wong, 1979) with the R Statistical Software (version 3.0.1; R Foundation for Statistical Computing, Vienna, Austria) (R-Core Team, 2013). The distinct clusters were further validated by measuring the Dunn Index with the clValid R Package (Brock et al., 2008).

Results

Virulence gene profiles of STEC strains from domestic farm animals

To further characterize the virulence potential of STEC strains recovered from domestic farm animals in the agricultural Culiacan Valley region in Mexico, the presence of genes, associated with pathogenic STEC strains, was identified. Our initial analysis focused on the identification of the subtypes of Stx, a virulence factor that has been attributed to the development of serious disease symptoms in humans (Karmali et al., 2010; Bolton, 2011; Melton-Celsa et al., 2012). The results indicated that 97% (28/29) of the O157 and non-O157 STEC strains, recovered from sheep, cattle and chickens, were PCR-positive for genes encoding stx2 subtypes (Table 4). By contrast, stx1 subtypes were only identified in the non-O157 strains from sheep and cattle. Interestingly, the stx2c subtype was detected in 51% (15/29) of the strains selected from the different animal sources and was predominantly identified in strains with the O157:H7 serotype (Table 4). Furthermore, the stx2d subtype was only identified in the ovine strain RM8749 belonging to serotype O20:H4. Our results also demonstrated that 45% (13/29) of the recovered STEC strains were positive for more than one gene encoding stx subtypes in the same strain. In particular, strains with serotypes O73:H4, O75:H8, O146:H8, and O146:H21 were found to harbor the stx gene profile stx1a, stx1c, and stx2b (Table 4). Moreover, the stx gene profile stx1a, stx2a, and stx2c was exclusively found in the O8:H19 strains recovered from cattle. None of the STEC strains recovered from domestic animals in rural farms in the Culiacan Valley were PCR-positive for the stx subtypes stx1d, stx2e, stx2f, or stx2g.

Table 4.

Identification of virulence genes in E. coli O157 and non-O157 strains used in this study.

Serotype Strain Source Virulence profile
O8:H19 RM8772 Cattle espP, saa, stx1a, stx2a, stx2c, subA
RM8776 Cattle
O15:NT RM8747 Cattle ent/espL2, espP, katP, stx2c
O20:H4 RM8749 Sheep stx2d
O73:NT RM8748 Cattle ent/espL2, espP, katP, stx2a
O73:H4 RM8745 Sheep stx1a, stx1c, stx2b
O75:H8 RM8752 Sheep iha, sheA, stx1a, stx1c, stx2b
RM8760 Sheep
RM8763 Sheep
RM8778 Sheep
RM8923 Cattle
RM8929 Sheep
RM13865 Cattle
O111:H8 RM8755 Sheep ent/espL2, espK, espN, iha, nleA, nleB, nleE, nleH1-2, sheA, stx1a
O146:H8 RM8762 Sheep iha, sheA, stx1a, stx1c, stx2b
O146:H21 RM8756 Sheep iha, sheA, stx1a, stx1c, stx2b
RM8761 Sheep
O157:H7 RM8744 Cattle ent/espL2, espK, espN, espP, etpD, iha, katP, nleA, nleB, nleE, nleH1-2, sheA, stx2c
RM8753 Sheep
RM8759 Sheep
RM8768 Cattle
RM8781 Sheep
RM8922 Cattle
RM9450 Sheep
RM9452 Sheep
RM9454 Cattle
RM9456 Cattle
RM9458 Chicken
RM9462 Cattle

Given that Stx is not the only virulence determinant that is responsible for full pathogenicity (Karmali et al., 2010; Bolton, 2011; Melton-Celsa et al., 2012), the STEC strains isolated from this agricultural region were further screened for the presence of additional markers encoding adhesins, cytotoxins, proteases, and other effectors. The virulence typing analysis revealed the presence of the non-LEE encoded effectors, nleA, nleB, nleE, and nleH1-2, in the recovered O157:H7 strains from sheep, cattle, and chicken as well as in the recovered O111:H8 strains from sheep (Table 4). Other effectors, espK, and espN, were also identified in the O157:H7 and O111:H8 strains. However, the plasmid-encoded etpD gene was only detected in the O157:H7 strains. Furthermore, saa and subA genes were exclusively identified in the O8:H19 cattle strains (Table 4). Finally, the iron-regulated adhesion gene (iha) and the cytolysin A gene (sheA) were both present in 79% (23/29) of the non-O157 and O157 strains. The ovine strains belonging to serotypes O20:H4 and O73:H4 were found to be negative for the presence of the accessory virulence determinants that were tested in the present study (Table 4).

STX activity in STEC strains isolated from domestic farm animals

A quantitative and sensitive cell-based assay was further employed to examine the activity of the Stxs expressed by the O157 and non-O157 strains recovered from domestic animals in the Culiacan Valley. A Vero cell line, Vero-d2EGFP, was employed to measure the inhibition of protein synthesis by Stx in mammalian cells (Quiñones et al., 2009; Quiñones and Swimley, 2011). Consequently, incubation with active Stx results in a reduction of the EGFP fluorescent signal that is detected from the Vero-d2EGFP cells (Quiñones et al., 2009; Quiñones and Swimley, 2011). Our results indicated low levels of fluorescence, ranging from 5.4 to 19.5%, were observed when the Vero-d2EGFP cells were incubated with culture supernatants from several STEC strains with the serotypes O8:H19, O75:H8, and O146:H8 (Figure 1), recovered from sheep and cattle. Further statistical analysis of the detected EGFP fluorescence indicated that these STEC strains with serotypes O8:H19, O75:H8 and O146:H8 belong to the same k-means cluster, suggesting that the Stx expressed by these non-O157 strains had similar effects on the EGFP fluorescence. Moreover, significantly reduced levels of EGFP fluorescence to approximately 16.7% were also observed after incubation with cell-free culture supernatants from the positive control O157:H7 strain RM2084 (Figure 1).

Figure 1.

Figure 1

Effect of Escherichia coli O157 and non-O157 culture supernatants on Vero-d2EGFP fluorescence. Vero-d2EGFP cells were incubated in Ham's F-12 complete medium containing tenfold dilutions of cell-free culture supernatants from the tested Escherichia coli O157 and non-O157 strains (Table 1). Cell-free culture supernatants from the Stx-producing E. coli O157:H7 strain RM2084 and from the non-Stx producing E. coli O157:H4 strain RM8928 were used as positive and negative controls, respectively. The average ± standard deviation of three independent experiments with duplicate samples for each strain is shown. Bars with the same lowercase letter represent significantly distinct clusters according to the k-means clustering algorithm and the clValid R Software package (Brock et al., 2008; R-Core Team, 2013).

Intermediate levels of EGFP fluorescence, ranging from 22.9 to 32.4% were observed after incubation with culture supernatants from the ovine STEC strains belonging to serotypes O20:H4, O73:H4, O111:H8, and O146:H21. Interestingly, analysis of the culture supernatants from all O157:H7strains, recovered from sheep, cattle and chickens in the Culiacan Valley, resulted in significantly higher levels of EGFP fluorescence (Figure 1). The levels of EGFP fluorescence when testing the supernatants from the O157:H7 strains in the Vero-cell based assay ranged from 38.0 to 62.6%. High levels of EGFP fluorescence that also belong to the same k-means cluster group as the O157:H7 strains were also observed when testing culture supernatants from the O15:NT and O73:NT strains (Figure 1). No reduction of EGFP fluorescence, averaging 98% detected fluorescence, was observed after incubation with culture supernatants from the negative control O157:H4 strain RM8928 strain lacking an stx gene (Figure 1). The fluorescence in the Vero-d2EGFP cells still remained when testing culture supernatants from an stx-negative O157:H7 strain RM4876 (Quiñones et al., 2009) or after incubation with bacterial growth media without toxin added (data not shown).

Discussion

In the present study, a genotyping and functional analysis was conducted to further characterize STEC strains, recovered from domestic animals in rural farms in the Culiacan Valley, which is considered one of the most important agricultural regions in Mexico (Amézquita-López et al., 2012). Given that the rural farms were located in communities that may not follow efficient management of animal wastes (Jiménez et al., 2011; Amézquita-López et al., 2012), an understanding of the virulence potential of the STEC strains recovered from animal reservoirs in this agricultural region would assist in the development of control measures to prevent the dispersal and transmission of pathogens throughout the environment that could lead to human infections associated with STEC.

The virulence typing analysis revealed that all O157:H7 and O111:H8 STEC strains from domestic animal reservoirs in the Culiacan Valley were positive for several of the nle genes, known to be located in the genomic islands OI-122 and OI-71 (Coombes et al., 2008). A previous study showed that these O157 and O111 STEC strains were also positive for eae (Amézquita-López et al., 2012). Thus, these findings revealed that these STEC strains from the Culiacan Valley harbor the gene signature, eae, ent/espL2, nleA, nleB, nleF, and nleH1-2, which has been proposed to be present in STEC strains with high virulence for humans (Bugarel et al., 2010a). Moreover, EtpD, the pO157 plasmid-encoded type II secretory pathway protein (Burland et al., 1998), was exclusively identified in O157:H7 strains. Finally, the STEC autoagglutinating adhesin (Saa) and subtilase cytotoxin (SubA) were specifically detected in the O8:H19 cattle strains, previously shown to be eae-negative and to display a limited genomic diversity by multiple-locus variable-number tandem repeat analysis (Amézquita-López et al., 2012). The findings from the present study are in agreement with other reports that documented Saa and SubA to be associated with non-O157 LEE-negative strains (Paton et al., 2001; Jenkins et al., 2003; Kumar et al., 2004; Toma et al., 2004; Zweifel et al., 2004; Kobayashi et al., 2013).

Approximately 79% of the O157 and non-O157 recovered STEC harbored both the iha and sheA genes. Previous studies demonstrated that iha, which codes for the iron-regulated gene A homolog adhesin, has been commonly observed in both LEE-positive as well as LEE-negative strains with different serotypes (Tarr et al., 2000; Schmidt et al., 2001). Moreover, sheA, encoding the cytolysin A or “silent hemolysin” has been shown to be prevalent in certain non-pathogenic E coli strains and in other enteropathogenic E. coli strains (Del Castillo et al., 1997; Fernández et al., 1998; Ludwig et al., 2004). All O157:H7 strains were positive for katP, a gene mostly identified in STEC strains belonging to seropathotypes associated with HUS (Bugarel et al., 2010b, 2011; Kobayashi et al., 2013). However, the present study also detected katP in O73:NT and O15:NT strains, belonging to serogroups not implicated in causing any human illness (Hussein, 2007).

To examine the relative toxicities of Stx subtypes expressed by the recovered STEC strains, the Vero-d2EGFP fluorescent assay was employed. The assay uses the Vero-d2EGFP cell line, expressing a destabilized variant of EGFP (Quiñones et al., 2009), and measures in mammalian cells the inhibition of protein synthesis by Stx (Quiñones et al., 2009; Quiñones and Swimley, 2011). Given that Vero cells are highly responsive to the effects of Stx (Keusch et al., 1995), the Vero-d2EGFP fluorescent assay is thus a sensitive and quantitative method to examine the potential relative toxicities of STEC strains. The results from the present study demonstrated that STEC strains with serotypes O8:H19, O75:H8, and O146:H8, serotypes previously associated with severe disease in humans (Boerlin et al., 1999; Blanco et al., 2003; Hussein, 2007), displayed a significant reduction in the EGFP signal from the Vero-d2EGFP cells to similar levels as the positive control O157:H7 strain RM2084. Moreover, the molecular typing study revealed that the stx gene profile stx1a, stx2a, and stx2c was exclusively found in the O8:H19 cattle strains while the stx1a, stx1c, and stx2b profile was detected in the O73:H4, O75:H8, O146:H8 and O146:H21 strains from cattle and sheep. In summary, these findings have indicated that these non-O157 strains, possessing multiple stx subtypes, appear to be more efficient at inhibiting protein synthesis in mammalian cells.

Interestingly, analysis of the Stx activity from the stx2c-positive O157:H7 strains, recovered from chicken, cattle, and sheep in the Culiacan Valley, indicated that the Vero-d2EGFP fluorescence levels were on average threefold higher when compared to the positive control O157:H7 strain RM2084. These findings suggested that the O157:H7 strains from this region in Mexico may have a significantly lower ability to inhibit protein synthesis in mammalian cells. Previous reports have documented that the Stx2a, Stx2c, and Stx2d subtypes have been associated with severe disease symptoms, including HUS and bloody diarrhea, as well as with differential toxicities in mammalian cells (Friedrich et al., 2002; Ethelberg et al., 2004; Persson et al., 2007; Manning et al., 2008; Müthing et al., 2009; Fuller et al., 2011; Quiñones and Swimley, 2011). However, recent evidence has indicated that purified Stx2c appears to have a reduced potency at inhibiting protein synthesis and metabolic activity in mammalian cells and a lower toxicity in mice (Fuller et al., 2011). The findings from the present study have demonstrated that the stx2c-positive O157:H7 strains from this region in Mexico, previously shown to be closely-related by multiple-locus variable-number tandem repeat analysis (Amézquita-López et al., 2012), were less toxic to Vero cells although they possessed other key accessory virulence factors.

Previous reports have documented that the amounts of Stx2 produced may define the severity of disease caused by STEC strains (Zhang et al., 2000; Dean-Nystrom et al., 2003; Muniesa et al., 2004), and the differential expression and induction of Stx2 subtypes appears to contribute to the relative virulence of the STEC strain (Muniesa et al., 2004; Zhang et al., 2005; De Sablet et al., 2008). Therefore, future work is aimed at further characterizing the amounts of Stx produced after induction under different conditions to obtain a more detail understanding of the pathogenic potential of O157 and non-O157 STEC strains from diverse sampling sites and sampling sources in the agricultural Culiacan Valley region in Mexico.

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Acknowledgments

This work was supported by the USDA-Agricultural Research Service CRIS project number 5325-42000-047-00D and by a Postgraduate Studies Scholarship from The National Council of Science and Technology in Mexico (CONACyT grant #234885) to Bianca A. Amézquita-López. The authors would like to thank Célida Martínez (CIAD in Culiacan, Sinaloa, Mexico) for excellent technical assistance.

References

  1. Amézquita-López B. A., Quiñones B., Cooley M. B., León-Félix J., Castro-Del Campo N., Mandrell R. E., et al. (2012). Genotypic analyses of Shiga toxin-producing Escherichia coli O157 and non-O157 recovered from feces of domestic animals on rural farms in Mexico. PLoS ONE 7:e51565 10.1371/journal.pone.0051565 [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bettelheim K. A. (2007). The non-O157 Shiga-toxigenic (Verocytotoxigenic) Escherichia coli; under-rated pathogens. Crit. Rev. Microbiol. 33, 67–87 10.1080/10408410601172172 [DOI] [PubMed] [Google Scholar]
  3. Beutin L., Krause G., Zimmermann S., Kaulfuss S., Gleier K. (2004). Characterization of Shiga toxin-producing Escherichia coli strains isolated from human patients in Germany over a 3-year period. J. Clin. Microbiol. 42, 1099–1108 10.1128/JCM.42.3.1099-1108.2004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Beutin L., Martin A. (2012). Outbreak of Shiga toxin-producing Escherichia coli (STEC) O104:H4 infection in Germany causes a paradigm shift with regard to human pathogenicity of STEC strains. J. Food Prot. 75, 408–418 10.4315/0362-028X.JFP-11-452 [DOI] [PubMed] [Google Scholar]
  5. Bielaszewska M., Friedrich A. W., Aldick T., Schurk-Bulgrin R., Karch H. (2006). Shiga toxin activatable by intestinal mucus in Escherichia coli isolated from humans: predictor for a severe clinical outcome. Clin. Infect. Dis. 43, 1160–1167 10.1086/508195 [DOI] [PubMed] [Google Scholar]
  6. Blanco M., Blanco J. E., Mora A., Rey J., Alonso J. M., Hermoso M., et al. (2003). Serotypes, virulence genes, and intimin types of Shiga toxin (verotoxin)-producing Escherichia coli isolates from healthy sheep in Spain. J. Clin. Microbiol. 41, 1351–1356 10.1128/JCM.41.4.1351-1356.2003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Boerlin P., McEwen S. A., Boerlin-Petzold F., Wilson J. B., Johnson R. P., Gyles C. L. (1999). Associations between virulence factors of Shiga toxin-producing Escherichia coli and disease in humans. J. Clin. Microbiol. 37, 497–503 [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Bolton D. J. (2011). Verocytotoxigenic (Shiga toxin-producing) Escherichia coli: virulence factors and pathogenicity in the farm to fork paradigm. Foodborne Pathog. Dis. 8, 357–365 10.1089/fpd.2010.0699 [DOI] [PubMed] [Google Scholar]
  9. Brock G., Pihur V., Datta S., Datta S. (2008). clValid: an R package for cluster validation. J. Stat. Softw. 25, 1–22 Available online at: http://www.jstatsoft.org/v25/i04/paper 20589883 [Google Scholar]
  10. Brooks J. T., Sowers E. G., Wells J. G., Greene K. D., Griffin P. M., Hoekstra R. M., et al. (2005). Non-O157 Shiga toxin-producing Escherichia coli infections in the United States, 1983-2002. J. Infect. Dis. 192, 1422–1429 10.1086/466536 [DOI] [PubMed] [Google Scholar]
  11. Bugarel M., Beutin L., Fach P. (2010a). Low-density macroarray targeting non-locus of enterocyte effacement effectors (nle genes) and major virulence factors of Shiga toxin-producing Escherichia coli (STEC): a new approach for molecular risk assessment of STEC isolates. Appl. Environ. Microbiol. 76, 203–211 10.1128/AEM.01921-09 [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Bugarel M., Beutin L., Martin A., Gill A., Fach P. (2010b). Micro-array for the identification of Shiga toxin-producing Escherichia coli (STEC) seropathotypes associated with Hemorrhagic Colitis and Hemolytic Uremic Syndrome in humans. Int. J. Food Microbiol. 142, 318–329 10.1016/j.ijfoodmicro.2010.07.010 [DOI] [PubMed] [Google Scholar]
  13. Bugarel M., Martin A., Fach P., Beutin L. (2011). Virulence gene profiling of enterohemorrhagic (EHEC) and enteropathogenic (EPEC) Escherichia coli strains: a basis for molecular risk assessment of typical and atypical EPEC strains. BMC Microbiol. 11:142 10.1186/1471-2180-11-142 [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Bürk C., Dietrich R., Acar G., Moravek M., Bulte M., Märtlbauer E. (2003). Identification and characterization of a new variant of Shiga toxin 1 in Escherichia coli ONT:H19 of bovine origin. J. Clin. Microbiol. 41, 2106–2112 10.1128/JCM.41.5.2106-2112.2003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Burland V., Shao Y., Perna N. T., Plunkett G., Sofia H. J., Blattner F. R. (1998). The complete DNA sequence and analysis of the large virulence plasmid of Escherichia coli O157:H7. Nucleic Acids Res. 26, 4196–4204 10.1093/nar/26.18.4196 [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Cooley M. B., Jay-Russell M., Atwill E. R., Carychao D., Nguyen K., Quiñones B., et al. (2013). Development of a robust method for isolation of Shiga toxin-positive Escherichia coli (STEC) from fecal, plant, soil and water samples from a leafy greens production region in California. PLoS ONE 8:e65716 10.1371/journal.pone.0065716 [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Cooley M., Carychao D., Crawford-Miksza L., Jay M. T., Myers C., Rose C., et al. (2007). Incidence and tracking of Escherichia coli O157:H7 in a major produce production region in California. PLoS ONE 2:e1159 10.1371/journal.pone.0001159 [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Coombes B. K., Gilmour M. W., Goodman C. D. (2011). The evolution of virulence in non-O157 Shiga toxin-producing Escherichia coli. Front. Microbiol. 2:90 10.3389/fmicb.2011.00090 [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Coombes B. K., Wickham M. E., Mascarenhas M., Gruenheid S., Finlay B. B., Karmali M. A. (2008). Molecular analysis as an aid to assess the public health risk of non-O157 Shiga toxin-producing Escherichia coli strains. Appl. Environ. Microbiol. 74, 2153–2160 10.1128/AEM.02566-07 [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Dean-Nystrom E. A., Melton-Celsa A. R., Pohlenz J. F., Moon H. W., O'Brien A. D. (2003). Comparative pathogenicity of Escherichia coli O157 and intimin-negative non-O157 Shiga toxin-producing E coli strains in neonatal pigs. Infect. Immun. 71, 6526–6533 10.1128/IAI.71.11.6526-6533.2003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Del Castillo F. J., Leal S. C., Moreno F., Del Castillo I. (1997). The Escherichia coli K-12 sheA gene encodes a 34-kDa secreted haemolysin. Mol. Microbiol. 25, 107–115 10.1046/j.1365-2958.1997.4391813.x [DOI] [PubMed] [Google Scholar]
  22. De Sablet T., Bertin Y., Vareille M., Girardeau J. P., Garrivier A., Gobert A. P., et al. (2008). Differential expression of stx2 variants in Shiga toxin-producing Escherichia coli belonging to seropathotypes A and C. Microbiology 154, 176–186 10.1099/mic.0.2007/009704-0 [DOI] [PubMed] [Google Scholar]
  23. Ethelberg S., Olsen K. E., Scheutz F., Jensen C., Schiellerup P., Enberg J., et al. (2004). Virulence factors for hemolytic uremic syndrome, Denmark. Emerg. Infect. Dis. 10, 842–847 10.3201/eid1005.030576 [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Feng P. C., Jinneman K., Scheutz F., Monday S. R. (2011). Specificity of PCR and serological assays in the detection of Escherichia coli Shiga toxin subtypes. Appl. Environ. Microbiol. 77, 6699–6702 10.1128/AEM.00370-11 [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Ferens W. A., Hovde C. J. (2011). Escherichia coli O157:H7: animal reservoir and sources of human infection. Foodborne Pathog. Dis. 8, 465–487 10.1089/fpd.2010.0673 [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Fernández S. V., Xing J., Kapur V., Libby S. J., Barletta R. G., Moxley R. A. (1998). Regulation of the Escherichia coli sheA gene and characterization of its encoded hemolytic activity. FEMS Microbiol. Lett. 168, 85–90 10.1016/S0378-1097(98)00413-3 [DOI] [PubMed] [Google Scholar]
  27. Friedrich A. W., Bielaszewska M., Zhang W. L., Pulz M., Kuczius T., Ammon A., et al. (2002). Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms. J. Infect. Dis. 185, 74–84 10.1086/338115 [DOI] [PubMed] [Google Scholar]
  28. Friedrich A. W., Borell J., Bielaszewska M., Fruth A., Tschape H., Karch H. (2003). Shiga toxin 1c-producing Escherichia coli strains: phenotypic and genetic characterization and association with human disease. J. Clin. Microbiol. 41, 2448–2453 10.1128/JCM.41.6.2448-2453.2003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Fuller C. A., Pellino C. A., Flagler M. J., Strasser J. E., Weiss A. A. (2011). Shiga toxin subtypes display dramatic differences in potency. Infect. Immun. 79, 1329–1337 10.1128/IAI.01182-10 [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Gould L. H., Bopp C., Strockbine N., Atkinson R., Baselski V., Body B., et al. (2009). Recommendations for diagnosis of Shiga toxin-producing Escherichia coli infections by clinical laboratories. MMWR Recomm. Rep. 58, 1–14 Available online at: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5812a1.htm [PubMed] [Google Scholar]
  31. Gyles C. L. (2007). Shiga toxin-producing Escherichia coli: an overview. J. Anim. Sci. 85, E45–E62 10.2527/jas.2006-508 [DOI] [PubMed] [Google Scholar]
  32. Hartigan J. A., Wong M. A. (1979). Algorithm AS 136: a k-means clustering algorithm. Appl. Stat. 28, 100–108 10.2307/2346830 [DOI] [Google Scholar]
  33. Hoefer D., Hurd S., Medus C., Cronquist A., Hanna S., Hatch J., et al. (2011). Laboratory practices for the identification of Shiga toxin-producing Escherichia coli in the United States, FoodNet sites, 2007. Foodborne Pathog. Dis. 8, 555–560 10.1089/fpd.2010.0764 [DOI] [PubMed] [Google Scholar]
  34. Hussein H. S. (2007). Prevalence and pathogenicity of Shiga toxin-producing Escherichia coli in beef cattle and their products. J. Anim. Sci. 85, E63–72 10.2527/jas.2006-421 [DOI] [PubMed] [Google Scholar]
  35. Ito H., Terai A., Kurazono H., Takeda Y., Nishibuchi M. (1990). Cloning and nucleotide sequencing of Vero toxin 2 variant genes from Escherichia coli O91:H21 isolated from a patient with the hemolytic uremic syndrome. Microb. Pathog. 8, 47–60 10.1016/0882-4010(90)90007-D [DOI] [PubMed] [Google Scholar]
  36. Jenkins C., Perry N. T., Cheasty T., Shaw D. J., Frankel G., Dougan G., et al. (2003). Distribution of the saa gene in strains of Shiga toxin-producing Escherichia coli of human and bovine origins. J. Clin. Microbiol. 41, 1775–1778 10.1128/JCM.41.4.1775-1778.2003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Jerse A. E., Yu J., Tall B. D., Kaper J. B. (1990). A genetic locus of enteropathogenic Escherichia coli necessary for the production of attaching and effacing lesions on tissue culture cells. Proc. Natl. Acad. Sci. U.S.A. 87, 7839–7843 10.1073/pnas.87.20.7839 [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Jiménez M., Martínez-Urtaza J., Chaidez C. (2011). Geographical and temporal dissemination of salmonellae isolated from domestic animal hosts in the Culiacan Valley, Mexico. Microb. Ecol. 61, 811–820 10.1007/s00248-010-9792-5 [DOI] [PubMed] [Google Scholar]
  39. Johnson K. E., Thorpe C. M., Sears C. L. (2006). The emerging clinical importance of non-O157 Shiga toxin-producing Escherichia coli. Clin. Infect. Dis. 43, 1587–1595 10.1086/509573 [DOI] [PubMed] [Google Scholar]
  40. Kaper J. B. (1998). The locus of enterocyte effacement pathogenicity island of Shiga toxin-producing Escherichia coli O157:H7 and other attaching and effacing E. coli. Jpn. J. Med. Sci. Biol. 51(Suppl), S101–S107 [DOI] [PubMed] [Google Scholar]
  41. Karmali M. A. (1989). Infection by verocytotoxin-producing Escherichia coli. Clin. Microbiol. Rev. 2, 15–38 [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Karmali M. A. (2009). Host and pathogen determinants of verocytotoxin-producing Escherichia coli-associated hemolytic uremic syndrome. Kidney Int. Suppl. 75, S4–S7 10.1038/ki.2008.608 [DOI] [PubMed] [Google Scholar]
  43. Karmali M. A., Gannon V., Sargeant J. M. (2010). Verocytotoxin-producing Escherichia coli (VTEC). Vet. Microbiol. 140, 360–370 10.1016/j.vetmic.2009.04.011 [DOI] [PubMed] [Google Scholar]
  44. Karmali M. A., Steele B. T., Petric M., Lim C. (1983). Sporadic cases of haemolytic-uraemic syndrome associated with faecal cytotoxin and cytotoxin-producing Escherichia coli in stools. Lancet 321, 619–620 10.1016/S0140-6736(83)91795-6 [DOI] [PubMed] [Google Scholar]
  45. Kerényi M., Allison H. E., Bátai I., Sonnevend Á., Emödy L., Plaveczky N., et al. (2005). Occurrence of hlyA and sheA genes in extraintestinal Escherichia coli strains. J. Clin. Microbiol. 43, 2965–2968 10.1128/JCM.43.6.2965-2968.2005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Keusch G. T., Jacewicz M., Acheson D. W., Donohue-Rolfe A., Kane A. V., McCluer R. H. (1995). Globotriaosylceramide, Gb3, is an alternative functional receptor for Shiga-like toxin 2e. Infect. Immun. 63, 1138–1141 [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Kobayashi N., Lee K. I., Yamazaki A., Saito S., Furukawa I., Kono T., et al. (2013). Virulence gene profiles and population genetic analysis for exploration of pathogenic serogroups of Shiga toxin-producing Escherichia coli. J. Clin. Microbiol. 51, 4022–4028 10.1128/JCM.01598-13 [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Koch C., Hertwig S., Lurz R., Appel B., Beutin L. (2001). Isolation of a lysogenic bacteriophage carrying the stx1OX3 gene, which is closely associated with Shiga toxin-producing Escherichia coli strains from sheep and humans. J. Clin. Microbiol. 39, 3992–3998 10.1128/JCM.39.11.3992-3998.2001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Kumar H. S., Karunasagar I., Teizou T., Shima K., Yamasaki S. (2004). Characterisation of Shiga toxin-producing Escherichia coli (STEC) isolated from seafood and beef. FEMS Microbiol. Lett. 233, 173–178 10.1016/j.femsle.2004.02.008 [DOI] [PubMed] [Google Scholar]
  50. Kyle J. L., Cummings C. A., Parker C. T., Quinones B., Vatta P., Newton E., et al. (2012). Escherichia coli serotype O55:H7 diversity supports parallel acquisition of bacteriophage at Shiga toxin phage insertion sites during evolution of the O157:H7 lineage. J. Bacteriol. 194, 1885–1896 10.1128/JB.00120-12 [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. La Ragione R. M., Best A., Woodward M. J., Wales A. D. (2009). Escherichia coli O157:H7 colonization in small domestic ruminants. FEMS Microbiol. Rev. 33, 394–410 10.1111/j.1574-6976.2008.00138.x [DOI] [PubMed] [Google Scholar]
  52. Leung P. H., Peiris J. S., Ng W. W., Robins-Browne R. M., Bettelheim K. A., Yam W. C. (2003). A newly discovered verotoxin variant, VT2g, produced by bovine verocytotoxigenic Escherichia coli. Appl. Environ. Microbiol. 69, 7549–7553 10.1128/AEM.69.12.7549-7553.2003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Ludwig A., Von Rhein C., Bauer S., Hüttinger C., Goebel W. (2004). Molecular analysis of cytolysin A (ClyA) in pathogenic Escherichia coli strains. J. Bacteriol. 186, 5311–5320 10.1128/JB.186.16.5311-5320.2004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Mandrell R. E. (2011). Tracing pathogens in fruit and vegetable production chains, in Tracing Pathogens in the Food Chain, eds Brul S., Fratamico P. M., McMeekin T. (Philadelphia, PA: Woodhead Publishing; ), 548–595 10.1533/9780857090508.4.548 [DOI] [Google Scholar]
  55. Manning S. D., Motiwala A. S., Springman A. C., Qi W., Lacher D. W., Ouellette L. M., et al. (2008). Variation in virulence among clades of Escherichia coli O157:H7 associated with disease outbreaks. Proc. Natl. Acad. Sci. U.S.A. 105, 4868–4873 10.1073/pnas.0710834105 [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Mathusa E. C., Chen Y., Enache E., Hontz L. (2010). Non-O157 Shiga toxin-producing Escherichia coli in foods. J. Food Prot. 73, 1721–1736 Available online at: http://www.ncbi.nlm.nih.gov/pubmed/20828483 [DOI] [PubMed] [Google Scholar]
  57. Melton-Celsa A., Mohawk K., Teel L., O'Brien A. (2012). Pathogenesis of Shiga-toxin producing Escherichia coli. Curr. Top. Microbiol. Immunol. 357, 67–103 10.1007/82_2011_176 [DOI] [PubMed] [Google Scholar]
  58. Muniesa M., Blanco J. E., De Simón M., Serra-Moreno R., Blanch A. R., Jofre J. (2004). Diversity of stx2 converting bacteriophages induced from Shiga-toxin-producing Escherichia coli strains isolated from cattle. Microbiology 150, 2959–2971 10.1099/mic.0.27188-0 [DOI] [PubMed] [Google Scholar]
  59. Müthing J., Schweppe C. H., Karch H., Friedrich A. W. (2009). Shiga toxins, glycosphingolipid diversity, and endothelial cell injury. Thromb. Haemost. 101, 252–264 10.1160/TH08-05-0317 [DOI] [PubMed] [Google Scholar]
  60. Nakao H., Kimura K., Murakami H., Maruyama T., Takeda T. (2002). Subtyping of Shiga toxin 2 variants in human-derived Shiga toxin-producing Escherichia coli strains isolated in Japan. FEMS Immunol. Med. Microbiol. 34, 289–297 10.1111/j.1574-695X.2002.tb00636.x [DOI] [PubMed] [Google Scholar]
  61. Ogden I. D., Macrae M., Strachan N. J. (2005). Concentration and prevalence of Escherichia coli O157 in sheep faeces at pasture in Scotland. J. Appl. Microbiol. 98, 646–651 10.1111/j.1365-2672.2004.02493.x [DOI] [PubMed] [Google Scholar]
  62. Paton A. W., Srimanote P., Woodrow M. C., Paton J. C. (2001). Characterization of Saa, a novel autoagglutinating adhesin produced by locus of enterocyte effacement-negative Shiga-toxigenic Escherichia coli strains that are virulent for humans. Infect. Immun. 69, 6999–7009 10.1128/IAI.69.11.6999-7009.2001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Persson S., Olsen K. E., Ethelberg S., Scheutz F. (2007). Subtyping method for Escherichia coli shiga toxin (verocytotoxin) 2 variants and correlations to clinical manifestations. J. Clin. Microbiol. 45, 2020–2024 10.1128/JCM.02591-06 [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Piérard D., Muyldermans G., Moriau L., Stevens D., Lauwers S. (1998). Identification of new verocytotoxin type 2 variant B-subunit genes in human and animal Escherichia coli isolates. J. Clin. Microbiol. 36, 3317–3322 [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Quiñones B., Massey S., Friedman M., Swimley M. S., Teter K. (2009). Novel cell-based method to detect Shiga toxin 2 from Escherichia coli O157:H7 and inhibitors of toxin activity. Appl. Environ. Microbiol. 75, 1410–1416 10.1128/AEM.02230-08 [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Quiñones B., Swimley M. S. (2011). Use of a Vero cell-based fluorescent assay to assess relative toxicities of Shiga toxin 2 subtypes from Escherichia coli. Methods Mol. Biol. 739, 61–71 10.1007/978-1-61779-102-4_6 [DOI] [PubMed] [Google Scholar]
  67. Quiñones B., Swimley M. S., Narm K.-E., Patel R. N., Cooley M. B., Mandrell R. E. (2012). O-antigen and virulence profiling of Shiga toxin-producing Escherichia coli by a rapid and cost-effective DNA microarray colorimetric method. Front. Cell. Inf. Microbiol. 2:61 10.3389/fcimb.2012.00061 [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Quiñones B., Swimley M. S., Taylor A. W., Dawson E. D. (2011). Identification of Escherichia coli O157 by using a novel colorimetric detection method with DNA microarrays. Foodborne Pathog. Dis. 8, 705–711 10.1089/fpd.2010.0753 [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. R-Core Team (2013). R Foundation for Statistical Computing. (Vienna: R: a language and environment for statistical computing; ). Available online at: http://www.R-project.org [Google Scholar]
  70. Reid S. D., Betting D. J., Whittam T. S. (1999). Molecular detection and identification of intimin alleles in pathogenic Escherichia coli by multiplex PCR. J. Clin. Microbiol. 37, 2719–2722 [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Scallan E., Hoekstra R. M., Angulo F. J., Tauxe R. V., Widdowson M. A., Roy S. L., et al. (2011). Foodborne illness acquired in the United States–major pathogens. Emerg. Infect. Dis. 17, 7–15 10.3201/eid1701.091101p1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Scheutz F., Strockbine N. A. (2005). Genus I. Escherichia., in Bergey's Manual of Systematic Bacteriology, eds Garrity G. M., Brenner D. J., Krieg N. R., Staley J. T. (New York, NY: Springer; ), 607–624 [Google Scholar]
  73. Scheutz F., Teel L. D., Beutin L., Piérard D., Buvens G., Karch H., et al. (2012). Multicenter evaluation of a sequence-based protocol for subtyping Shiga toxins and standardizing Stx nomenclature. J. Clin. Microbiol. 50, 2951–2963 10.1128/JCM.00860-12 [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Schmidt H., Zhang W. L., Hemmrich U., Jelacic S., Brunder W., Tarr P. I., et al. (2001). Identification and characterization of a novel genomic island integrated at selC in locus of enterocyte effacement-negative, Shiga toxin-producing Escherichia coli. Infect. Immun. 69, 6863–6873 10.1128/IAI.69.11.6863-6873.2001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Schmitt C. K., McKee M. L., O'Brien A. D. (1991). Two copies of Shiga-like toxin II-related genes common in enterohemorrhagic Escherichia coli strains are responsible for the antigenic heterogeneity of the O157:H- strain E32511. Infect. Immun. 59, 1065–1073 [DOI] [PMC free article] [PubMed] [Google Scholar]
  76. Stigi K. A., Macdonald J. K., Tellez-Marfin A. A., Lofy K. H. (2012). Laboratory practices and incidence of non-O157 Shiga toxin-producing Escherichia coli infections. Emerg. Infect. Dis. 18, 477–479 10.3201/eid1803.111358 [DOI] [PMC free article] [PubMed] [Google Scholar]
  77. Tarr P. I., Bilge S. S., Vary J. C., Jr., Jelacic S., Habeeb R. L., Ward T. R., et al. (2000). Iha: a novel Escherichia coli O157:H7 adherence-conferring molecule encoded on a recently acquired chromosomal island of conserved structure. Infect. Immun. 68, 1400–1407 10.1128/IAI.68.3.1400-1407.2000 [DOI] [PMC free article] [PubMed] [Google Scholar]
  78. Tarr P. I., Gordon C. A., Chandler W. L. (2005). Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet 365, 1073–1086 10.1016/S0140-6736(05)71144-2 [DOI] [PubMed] [Google Scholar]
  79. Toma C., Martinez Espinosa E., Song T., Miliwebsky E., Chinen I., Iyoda S., et al. (2004). Distribution of putative adhesins in different seropathotypes of Shiga toxin-producing Escherichia coli. J. Clin. Microbiol. 42, 4937–4946 10.1128/JCM.42.11.4937-4946.2004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. Weinstein D. L., Jackson M. P., Samuel J. E., Holmes R. K., O'Brien A. D. (1988). Cloning and sequencing of a Shiga-like toxin type II variant from Escherichia coli strain responsible for edema disease of swine. J. Bacteriol. 170, 4223–4230 [DOI] [PMC free article] [PubMed] [Google Scholar]
  81. Zhang W., Bielaszewska M., Friedrich A. W., Kuczius T., Karch H. (2005). Transcriptional analysis of genes encoding Shiga toxin 2 and its variants in Escherichia coli. Appl. Environ. Microbiol. 71, 558–561 10.1128/AEM.71.1.558-561.2005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  82. Zhang X., McDaniel A. D., Wolf L. E., Keusch G. T., Waldor M. K., Acheson D. W. (2000). Quinolone antibiotics induce Shiga toxin-encoding bacteriophages, toxin production, and death in mice. J. Infect. Dis. 181, 664–670 10.1086/315239 [DOI] [PubMed] [Google Scholar]
  83. Zheng J., Cui S., Teel L. D., Zhao S., Singh R., O'Brien A. D., et al. (2008). Identification and characterization of Shiga toxin type 2 variants in Escherichia coli isolates from animals, food, and humans. Appl. Environ. Microbiol. 74, 5645–5652 10.1128/AEM.00503-08 [DOI] [PMC free article] [PubMed] [Google Scholar]
  84. Zweifel C., Blanco J. E., Blanco M., Blanco J., Stephan R. (2004). Serotypes and virulence genes of ovine non-O157 Shiga toxin-producing Escherichia coli in Switzerland. Int. J. Food Microbiol. 95, 19–27 10.1016/j.ijfoodmicro.2004.01.015 [DOI] [PubMed] [Google Scholar]

Articles from Frontiers in Cellular and Infection Microbiology are provided here courtesy of Frontiers Media SA

RESOURCES